Anest. intenziv. Med. 2006;17(5):241-245

Duration of rocuronium-induced neuromuscular block predicted by its dose and onset time: a prospective studyAnaesthesiology - Original Paper

M. Adamus1, P. Adamus2, R. Bělohlávek3, M. Vujčíková1, E. Janásková1
1 Klinika anesteziologie a resuscitace, LF Univerzity Palackého a Fakultní nemocnice, Olomouc
2 Rapid System, s. r. o., Olomouc
3 Katedra informatiky, PřF Univerzity Palackého, Olomouc

Objective:
Following a bolus dose of rocuronium, the average duration of neuromuscular block until 25% recovery (= clinical duration) can be predicted by the dose-duration relationship. In the present study we investigated whether the predictive power could be improved by the addition of another independent variable - onset time.

Design:
Clinical, prospective, randomized, controlled study.


Settings:
Department of Anaesthesiology and Intensive Care, University Hospital, Olomouc.

Materials and Methods:
Following local ethics committee approval and obtaining informed consent, 350 patients scheduled for elective surgery under total intravenous anaesthesia with tracheal intubation were randomized into 7 groups with different rocuronium doses administered (0.30; 0.45; 0.60; 0.75; 0.90; 1.05; 1.20 mg . kg⁻1, respectively). For each consecutive patient the onset time for 95% depression of T1 and clinical duration until 25% recovery were determined. To predict clinical duration for different values of two independent variables (dose and onset time), statistical analyses were performed by simple and multiple linear regression (least-square method). The squared correlation coefficient (r2) was used as the primary criterion for the evaluation of each model. In addition, the possible useful effect of different transformations of the variables was studied.

Results:
The duration of action was better predicted by dose (r2 = 0.64) than by onset time (r2 = 0.59). The predictability of clinical duration was improved by combining the two independent variables (dose and onset time) in a multiple regression model (r2 = 0.68). The explanatory power was further increased when using the logarithm of clinical duration as the dependent variable (r2 = 0.72).

Conclusion: The duration of rocuronium-induced neuromuscular block can be predicted more precisely by the combined use of dose and onset time than by dose (or onset time) alone. The addition of an individual response parameter, the onset time, improved the prediction of the duration of action.

Keywords: neuromuscular block; rocuronium; clinical duration; onset time; simple and multiple linear regression analysis

Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamus M, Adamus P, Bělohlávek R, Vujčíková M, Janásková E. Duration of rocuronium-induced neuromuscular block predicted by its dose and onset time: a prospective study. Anest. intenziv. Med. 2006;17(5):241-245.
Download citation

References

  1. Herold, I. Svalová relaxancia v anesteziologii a intenzivní péči. 1. vydání. Praha : Maxdorf 2004, 268 s., ISBN 80-7345-025-9.
  2. Adamus, M., Adamus, P., Bělohlávek, R., Vujčíková, M., Janásková, E. Vliv odlišných dávek rokuronia na jeho farmakodynamický profil: prospektivní studie. Anest. intenziv. Med., 2004, 15, s. 269-275.
  3. Rorvik, K., Husby, P., Gramstad, L., Vamnes, J. S., Boe, O. E. Duration of vecuronium-induced neuromuscular blockade predicted by dose and onset time. Acta Anaesthesiologica Scandinavica, 1993, 37, p. 481-483. Go to original source... Go to PubMed...
  4. References and formulas used by the Body Surface Area Calculator. Formula for Body Mass Index. Formulas for Body Surface Area (on line) [citováno 12. července 2006]. Dostupné na www: http://www.halls.md/body-surface-area/refs.htm.
  5. Servin, F., Cazalaa, J. B., Levron, J. C. Propofol, Sufentanil, Remifentanil in TCI. Bibliographical study of anesthetic agents used in the Base Primea®, Fresenius Vial. Le Grand Chemin, Brezins (France) : Fresenius Vial; 2003.
  6. Viby-Mogensen, J., Engbaek, J., Eriksson, L. I., Gramstad, L., Jensen, E., Jensen, F. S. et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesth. Scand., 1996, 40, p. 59-74. Go to original source... Go to PubMed...
  7. Viby-Mogensen, J., Ostergaard, D., Donati, F., Fisher, D., Hunter, J., Kampmann, J. P. Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP). Acta Anaesth. Scand., 2000, 44, p. 1169-1190. Go to original source... Go to PubMed...
  8. Adamus, M., Bělohlávek, R. Automatické dávkování svalových relaxancií u náročných neurochirurgických výkonů. Čes. Slov. Neurol. Nerochir., (v tisku).
  9. Kasal, P., Svačina, Š. et al. Lékařská informatika. 1. vydání. Praha : Karolinum - nakladatelství Univerzity Karlovy 1998, 543 s. ISBN 80-7184-594-9.
  10. Zbinden, A., M.,Thomson, D. Conducting Research in Anaesthesia and Intensive Care Medicine. 1. vydání. Oxford : Butterworth-Heinemann 2001, 550 p. ISBN 0-7506-4544-X.
  11. Muchhal, K. K., Viby-Mogensen, J., Fernando, P. U. E., Tamilarasan, A., Bonsu, A. K., Lambourne, A. Evaluation of intense neuromuscular blockade caused by vecuronium using posttetanic count (PTC). Anesthesiology, 1987, 66, p. 846-849. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.